Y. Inagaki, W. Tang, M. Makuuchi, et al., “Clinical and Molecular Insights into the Hepatocellular Carcinoma Tumour Marker Des-γ-Carboxyprothrombin,” Liver International, Vol. 31, No. 1, 2011, pp. 22-35.
doi:10.1111/j.1478-3231.2010.02348.x
-
TITLE:
Relationship between Serum Hyaluronic Acid Level and Patient Prognosis in Hepatocellular Carcinoma Patients Who Underwent Hepatectomy
AUTHORS:
Atsushi Nanashima, Takafumi Abo, Goushi Murakami, Masaki Kunizaki, Hiroaki Takeshita, Shigekazu Hidaka, Kazuo To, Tomoshi Tsuchiya, Takeshi Nagayasu
KEYWORDS:
Hepatocellular Carcinoma; Hepatectomy; Serum Hyaluronic Acid Level; Prognosis
JOURNAL NAME:
Journal of Cancer Therapy,
Vol.4 No.2A,
February
28,
2013
ABSTRACT:
We examined the relationship between hyaluronic acid (HA) and tumor-related factors after hepatectomy in 158 patients with hepatocellular carcinoma (HCC) who underwent hepatectomy. We examined serum HA levels before hepatectomy by evaluating data for clinicopathological parameters, surgical records, postoperative complications and survival. The mean HA level was 190 ± 202 ng/ml. Patients were divided into 3 groups: group A had serum HA levels less than 50 ng/ml (normal range), group B had levels between 50 and 190 ng/ml, and group C had levels over 190 ng/ml. Group C had a higher rate of poor liver function compared to others. Multiple tumors were significantly more frequent in groups B and C compared to A. The grade of fibrosis and the inflammatory responses were positively correlated with the serum HA level. Postoperative long-term ascites was significantly more frequent in group C compared to others. Although the recurrence rate and the relapse-free period were not significantly related to the serum HA level, the serum HA level was significantly associated with overall survival after hepatectomy (p 0.05). Cox’s multivariate analysis did not show a significant relationship between HA level and survival. Serum HA reflects progression and survival in HCC patients.
Related Articles:
Alteration of liver N-glycome in patients with hepatocellular carcinoma
Ling Wang, Valerie Vanhooren, Sylviane Dewaele, Xue-En Liu, Claude Libert, Feng-Min Lu, Hui Zhuang, Cuiying Chitty Chen
DOI:
10.4236/ojgas.2012.21001
3,944 Downloads 7,540 Views Citations
Pub. Date:
February
15,
2012
Serum SCCA-IgM as a predictor of hepatocellular carcinoma in patients with liver cirrhosis
Daniela Buccione, Gianluca Fatti, Andrea Gallotta, Elisabetta Loggi, Roberto Di Donato, Lilia Testa, Carlo Saitta, Valentina Santi, Antonio Di Micoli, Virginia Erroi, Marta Frigerio, Valentina Fazio, Antonino Picciotto, Alessandra Biasiolo, Francoise Degos, Patrizia Pontisso, Giovanni Raimondo, Franco Trevisani
DOI:
10.4236/ojgas.2012.22012
4,261 Downloads 7,688 Views Citations
Pub. Date:
March
30,
2012
